Annals of oncology : official journal of the European Society for Medical Oncology
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.
F Turco, U M Vogl, H M Lin, M Pedrani, G Leone, S Gillessen
Published: 202510.1016/j.annonc.2025.12.007
No abstract available for this study.